Ottawa resident Andrew Konency has launched a petition to limit the off-label use of Ozempic, a drug that has become a popular tool in the weight loss industry. In fact, the demand for this drug is so sky-high that it has sparked recent shortages across North America. But for diabetic patients that need Ozempic to manage their massive health adjustments, the search for alternatives has been a challenging chore. Andrew joins Kristy Cameron on today’s Ottawa Now.